{"id":944,"date":"2019-12-04T16:35:12","date_gmt":"2019-12-04T15:35:12","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=944"},"modified":"2019-12-04T16:35:12","modified_gmt":"2019-12-04T15:35:12","slug":"por-nacimiento-de-hijosas-prematuros-2","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/por-nacimiento-de-hijosas-prematuros-2\/","title":{"rendered":"Per naixement de fills\/as prematurs"},"content":{"rendered":"<p>En els casos de naixements de fills prematurs o que, per qualsevol causa, hagin de romandre hospitalitzats a continuaci\u00f3 del part, la mare o el pare tindran dret a absentar-se del treball durant una hora.    \t    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>En els casos de naixements de fills prematurs o que, per qualsevol causa, hagin de romandre hospitalitzats a continuaci\u00f3 del part, la mare o el pare tindran dret a absentar-se &#8230; <a title=\"Per naixement de fills\/as prematurs\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/por-nacimiento-de-hijosas-prematuros-2\/\" aria-label=\"Leer m\u00e1s sobre Per naixement de fills\/as prematurs\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":351,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"class_list":["post-944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-permisosllicencies_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=944"}],"version-history":[{"count":0,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/944\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/351"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}